Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-028479)

Filing Details

Accession Number:: 0001104659-23-028479
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-03 16:47:47
Reporting Period:: 2023-03-01

Accepted Time:: 2023-03-03 16:47:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1297184	Amphastar Pharmaceuticals Inc.	AMPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263136	J William Peters	C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730	Cfo, Evp & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-01	10,974	$11.33	111,588	No	4	M	Direct
Common Stock	Disposition	2023-03-01	10,974	$36.33	100,614	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2023-03-01	10,974	$0.00	10,974	$11.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,826		2026-03-17	No	4	M	Direct

Footnotes

Includes 134 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2022.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022.
Shares subject to the option are fully vested and immediately exercisable.